The origin of ovarian cancer.

The origin of ovarian cancer.

Bibliographic Details
Main Authors:	Ahmed, A, Becker, C, Bast, R
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Cell Origins of High-Grade Serous Ovarian Cancer
by: Jaeyeon Kim, et al.
Published: (2018-11-01)

On the origin, progression, and evolution of ovarian cancer
by: KaramiNejadRanjbar, M
Published: (2018)

Reply to Comment on “Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer” <i>Cancers</i> 2019, <i>11</i>, 596: Markers for Early Detection of Ovarian Cancer
by: Jing Guo, et al.
Published: (2019-09-01)

Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy
by: Kosuke Murakami, et al.
Published: (2020-06-01)

Loss of PFKFB4 induces cell death in mitotically arrested ovarian cancer cells
by: Taylor, C, et al.
Published: (2017)

Ovarian cancer: the Fallopian tube as the site of origin and opportunities for prevention
by: Sophia HL George, PhD, et al.
Published: (2016-05-01)

A genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancer.
by: Ahmed, A, et al.
Published: (2011)

Targeting tyrosine-kinases in ovarian cancer.
by: Morotti, M, et al.
Published: (2013)

The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells.
by: Le, X, et al.
Published: (2011)

Optimization of early diagnosis of ovarian cancer using an original software ScOv
by: S. V. Khabarov, et al.
Published: (2019-09-01)

A Novel Salt Inducible Kinase 2 Inhibitor, ARN-3261, Sensitizes Ovarian Cancer Cell Lines and Xenografts to Carboplatin
by: Dengxuan Fan, et al.
Published: (2021-01-01)

A novel salt inducible kinase 2 inhibitor, ARN-3261, sensitizes ovarian cancer cell lines and xenografts to carboplatin
by: Fan, D, et al.
Published: (2021)

Paclitaxel sensitivity of ovarian cancer can be enhanced by knocking down pairs of kinases that regulate MAP4 phosphorylation and microtubule stability
by: Yang, H, et al.
Published: (2018)

Pseudomyxoma peritonei of appendiceal origin mimicking ovarian cancer – a case report with literature review
by: Stoyan Kostov, et al.
Published: (2021-09-01)

Subtypes of Ovarian Cancer and Ovarian Cancer Screening
by: Masafumi Koshiyama, et al.
Published: (2017-03-01)

Development of a Multiprotein Classifier for the Detection of Early Stage Ovarian Cancer
by: Kristin L. M. Boylan, et al.
Published: (2022-06-01)

miRNA Expression Profiles in Ovarian Endometriosis and Two Types of Ovarian Cancer—Endometriosis-Associated Ovarian Cancer and High-Grade Ovarian Cancer
by: Maria Szubert, et al.
Published: (2023-12-01)

Ovarian Fibroma as a Possible Cause of Fever of Unknown Origin
by: İkbal Kaygusuz, et al.
Published: (2016-02-01)

Establishment of cancer cell line originating from a patient with high-grade serous ovarian carcinoma
by: Nguyen Thuy Linh, et al.
Published: (2023-09-01)

Androgens are differentially associated with ovarian cancer subtypes in the Ovarian Cancer Cohort Consortium
by: Ose, J, et al.
Published: (2017)

Galectins and Ovarian Cancer
by: Chisa Shimada, et al.
Published: (2020-05-01)

An experimental model for ovarian cancer: propagation of ovarian cancer initiating cells and generation of ovarian cancer organoids
by: Yu-An Chen, et al.
Published: (2022-09-01)

A MYC-Driven Plasma Polyamine Signature for Early Detection of Ovarian Cancer
by: Johannes F. Fahrmann, et al.
Published: (2021-02-01)

Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer
by: Moore Carla L, et al.
Published: (2010-03-01)

Innate Immune Program in Formation of Tumor-Initiating Cells from Cells-of-Origin of Breast, Prostate, and Ovarian Cancers
by: Sen Han, et al.
Published: (2023-01-01)

Effects of lysate/tissue storage at −80°C on subsequently extracted EVs of epithelial ovarian cancer tissue origins
by: Shizhen Shen, et al.
Published: (2023-04-01)

Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq.
by: Andrew J Shih, et al.
Published: (2018-01-01)

Fallopian tube origin of supposed ovarian high-grade serous carcinomas
by: Patricia Martini Diniz, et al.
Published: (2011-01-01)

Non-Gestational Ovarian Choriocarcinoma: A Rare Ovarian Cancer Subtype
by: Sean Cronin, et al.
Published: (2022-02-01)

Hereditary ovarian cancer
by: Kh. B. Kotiv, et al.
Published: (2022-11-01)

Ovarian cancer risk factors by histologic subtype: an analysis from the Ovarian Cancer Cohort Consortium
by: Wentzensen, N, et al.
Published: (2016)

A novel compound ARN-3236 inhibits salt-inducible kinase 2 and sensitizes ovarian cancer cell lines and xenografts to paclitaxel.
by: Zhou, J, et al.
Published: (2016)

Ovarian cancer ascites confers platinum chemoresistance to ovarian cancer cells
by: Yifat Koren Carmi, et al.
Published: (2024-06-01)

Animal models of ovarian cancer
by: Shaw Tanya J, et al.
Published: (2003-10-01)

Ovarian Microbiota, Ovarian Cancer and the Underestimated Role of HPV
by: Massimiliano Cazzaniga, et al.
Published: (2022-12-01)

Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
by: Yi Hu, et al.
Published: (2023-01-01)

Endometriosis-associated ovarian cancer
by: S. A. Levakov, et al.
Published: (2017-02-01)

Highly Differentiated Follicular Carcinoma of Ovarian Origin: A Systematic Review of the Literature
by: Eirini Giovannopoulou, et al.
Published: (2022-11-01)

Aberrant Ovarian Artery Originating from the Iliolumbar Artery: A Case Report
by: Ji Eun Lee, et al.
Published: (2016-05-01)

Environmental toxicant induced epigenetic transgenerational inheritance of ovarian pathology and granulosa cell epigenome and transcriptome alterations: ancestral origins of polycystic ovarian syndrome and primary ovarian insufficiency
by: Eric Nilsson, et al.
Published: (2018-08-01)